4D Molecular Therapeutics (FDMT) Treasury Shares (2019 - 2020)

4D Molecular Therapeutics (FDMT) has reported Treasury Shares for 6 consecutive years, with $1.6 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Treasury Shares rose 113.08% year-over-year to $1.6 million; the TTM figure through Mar 2026 stood at $1.6 million (up 113.08% YoY), while the FY2025 annual figure was $744770.0, up 105.74% from the prior year.
• Treasury Shares grew to $1.6 million in Q1 2026 per FDMT's latest filing, from $744770.0 in the prior quarter.
• Across five years, Treasury Shares topped out at $1.6 million in Q1 2026 and bottomed at $181181.0 in Q4 2023.
• Historically, Treasury Shares has averaged $585078.7 across 4 years, with a median of $530008.0 in 2024.
• Annual changes were most pronounced in 2024 — Treasury Shares jumped 99.8% — and 2025, when it jumped 256.54%.
• 4D Molecular Therapeutics' Treasury Shares stood at $181181.0 in 2023, then soared by 99.8% to $361997.0 in 2024, then jumped by 105.74% to $744770.0 in 2025, then jumped by 114.11% to $1.6 million in 2026.
• Business Quant data shows FDMT's Treasury Shares at $1.6 million in Q1 2026, $744770.0 in Q4 2025, and $698019.0 in Q3 2025.